Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV dexamethasone 10 mg vs 20 mg for prevention of paclitaxel hypersensitivity in gynecologic cancer
TCTR20201215005Phase 1Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexamethasone in drug allergy (2 arms), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoint: Incidence of paclitaxel hypersensitivity reaction. Started Apr 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
drug allergy
Beyond the preview
Go deeper on TCTR20201215005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201215005.